1 / 6

Aortic Valve Market Growth Insights and Forecast To 2027, Key Player - LivaNova

The global aortic valve market is anticipated to grow t a CAGR of 13.1% during the forecast period 2021-2027 owing to the rising prominence of valvular diseases and awareness on valve replacement will propel the growth of the aortic valve market. Moreover, the rise in the adoption of minimally invasive surgeries and industry players are building strategic initiatives like partnerships, collaboration, and joint ventures with hospitals and ambulatory centers to have a competitive edge in the market.

Research1
Download Presentation

Aortic Valve Market Growth Insights and Forecast To 2027, Key Player - LivaNova

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Aortic Valve Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Aortic Valve Market The global aortic valve market is anticipated to grow t a CAGR of 13.1% during the forecast period 2021-2027 owing to the rising prominence of valvular diseases and awareness on valve replacement will propel the growth of the aortic valve market. Moreover, the rise in the adoption of minimally invasive surgeries and industry players are building strategic initiatives like partnerships, collaboration, and joint ventures with hospitals and ambulatory centers to have a competitive edge in the market. The COVID-19 pandemic has had an adverse impact on the aortic valve market owing to strict lockdown and non-operational hospitals in many countries. There was a decrease in the sale of many products including aortic valves, resulting in less demand. Moreover, there was the temporary closure of manufacturing facilities, constraints in the handling capacity of goods at ports, and extensive financial distress.

  4. Global Aortic Valve Market Based on surgery type, minimally invasive surgeries are anticipated to have a significant share during 2021-2027 owing to the rising prominence of transcatheter aortic valve replacement that causes less trauma to the patient and have a speedy recovery. Furthermore, minimally invasive surgeries require a reduced hospital stay and are economically viable. Europe holds a significant share in the aortic valve market owing to the developed healthcare infrastructure, increased spending on healthcare, rising geriatric population, mounting prevalence of chronic and lifestyle-related diseases in the region. Furthermore, a substantial occurrence of aortic stenosis, the advent of effective treatments, like transcatheter aortic valve replacement (TAVR), and intensifying initiatives to create awareness regarding valve replacement surgeries will propel the growth in the European market.

  5. Global Aortic Valve Market Edwards Lifesciences Corporation has received Chinese regulatory approval for Edwards SAPIEN 3 transcatheter heart valve, to treat patients suffering from severe, symptomatic aortic stenosis (AS), that are not able to undergo open-heart surgery or for highly risky invasive procedures. Medtronic plc has received FDA approval and launched in US Evolut PRO+ TAVR system that offers a low delivery profile and added surface area contact between the valve and the native aortic annulus, to further develop valve sealing performance. The key players operating in the aortic valve industry include Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, Abbott Laboratories, CryoLife Inc., and Medtronic plc.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/aortic-valve-market/request-sample www.vynzresearch.com

More Related